Figure 1.

General principle of the bMAB assay. Binding of the target results in the conformational change in the MAB, allowing separation of the tethered inhibitor from Gluc and subsequent binding of the substrate. While the IFN-γ crystal structure has been resolved (PDB 1HIG), an example protein structure has been included to represent Gluc, as the crystal structure is unknown.